Lonza Group AG (LZAGY)

Currency in USD
70.43
-1.60(-2.22%)
Closed·
After Hours
70.430.00(0.00%)
·
LZAGY Scorecard
Full Analysis
Management has been aggressively buying back shares
LZAGY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
70.3271.44
52 wk Range
55.5773.29
Key Statistics
Prev. Close
72.03
Open
71.44
Day's Range
70.32-71.44
52 wk Range
55.57-73.29
Volume
25.19K
Average Volume (3m)
65.6K
1-Year Change
10.82%
Book Value / Share
153.83
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LZAGY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
80.35
Upside
+14.08%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Lonza Group AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Lonza Group AG Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. Its Small Molecules segment provides integrated development and manufacturing services for small molecule drug substances and their intermediates. This segment also supports customers across aspects of design, development, and manufacturing, such as particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. Its Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Compare LZAGY to Peers and Sector

Metrics to compare
LZAGY
Peers
Sector
Relationship
P/E Ratio
55.9x26.9x−0.5x
PEG Ratio
1.810.010.00
Price/Book
4.8x2.9x2.6x
Price / LTM Sales
5.8x4.1x3.3x
Upside (Analyst Target)
12.6%23.5%42.4%
Fair Value Upside
Unlock18.5%7.2%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 80.35
(+14.08% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 10.39%
Dividend Yield
0.42%
Industry Median 0.68%
Annualised payout
0.30
Paid unevenly
5-Years Growth
+7.78%
Growth Streak

Earnings

Latest Release
Jul 23, 2025
EPS / Forecast
6.07 / --
Revenue / Forecast
3.58B / --
EPS Revisions
Last 90 days

LZAGY Income Statement

People Also Watch

13.60
TAK
-5.03%
106.75
BSX
+0.26%
148.310
ESLOY
-2.04%
50.03
NVO
-7.25%

FAQ

What Stock Exchange Does Lonza Group AG Trade On?

Lonza Group AG is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Lonza Group AG?

The stock symbol for Lonza Group AG is "LZAGY."

What Is the Lonza Group AG Market Cap?

As of today, Lonza Group AG market cap is 49.83B.

What Is Lonza Group AG's Earnings Per Share (TTM)?

The Lonza Group AG EPS (TTM) is 10.39.

When Is the Next Lonza Group AG Earnings Date?

Lonza Group AG will release its next earnings report on 20 Oct 2025.

From a Technical Analysis Perspective, Is LZAGY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Lonza Group AG Stock Split?

Lonza Group AG has split 0 times.

How Many Employees Does Lonza Group AG Have?

Lonza Group AG has 19299 employees.

What is the current trading status of Lonza Group AG (LZAGY)?

As of 30 Jul 2025, Lonza Group AG (LZAGY) is trading at a price of 70.43, with a previous close of 72.03. The stock has fluctuated within a day range of 70.32 to 71.44, while its 52-week range spans from 55.57 to 73.29.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.